Phase 1 study of alisertib with concurrent fractionated stereotactic radiation treatment for recurrent high grade gliomas

Authors
Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2017
This article has no abstract
Epistemonikos ID: b115ec9a596833261eb20a00d61292b9d84186ce
First added on: Feb 08, 2025